NoBlaBlaFinance

Filings Companies Sectors Calendar

Log in Français

Cellectis

Health careALCLSFR0010425595

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.

Filings

8 filings

All Inside information43 Voting rights and capital39 Earnings release8 Quarterly financial information8 Annual financial report2 Half-year financial report2

04/05/2026
Cellectis to Report First Quarter Financial Results on May 11, 2026
Earnings releaseFR
20/03/2026
Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update
Earnings releaseFR
12/03/2026
Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
Earnings release
06/05/2025
Cellectis to Report First Quarter Financial Results on May 12, 2025
Earnings releaseFR
07/03/2025
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
Earnings release

About

ISIN: FR0010425595
Ticker: ALCLS
LEI: 5493000KKX5VQ37Q2W83
Sector: Health care
Founded: 1999
Country of registration: FR
Last filing: 06/08/2026, 22:30

Description from Wikidata, CC0 licence.

Filing history

Filings per month

10

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive

Others in this sector